SCHEMBL10028159

SCHEMBL10028159

c1ccc2c(-c3c4ccccc4c4ccc5oc6c(-c7ccnc8ccccc78)c7ccccc7c7ccc8oc3c4c5-c8c67)ccnc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 4/20 0.39
CYP1A2 P05177 1/20 0.38
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 4/20 0.36
ESR1 P03372 1/20 0.36
TP53 P04637 1/20 0.36
PTK2B Q14289 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TGFBR1 P36897 5/20 0.36
MAPK14 Q16539 5/20 0.36
NCF1 P14598 1/20 0.36
NCOA1 Q15788 1/20 0.35
NFATC1 O95644 1/20 0.35
DYRK1A Q13627 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10028153 0.77 ALDH1A1 (0.38) CYP1A2ALDH1A1MAPK1KDM4EHPGD
SCHEMBL10028162 0.75 CYP1A2 (0.39) CYP1A2ALDH1A1MAPK1KDM4EHPGD
SCHEMBL10028155 0.72 CA1 (0.37) CYP1A2RAB9ANPC1ALDH1A1MAPK1
SCHEMBL10028092 0.70 ACVR1 (0.41) GRM4CYP1A2RAB9ANPC1ALDH1A1
SCHEMBL1227713 0.69 CYP1A2 (0.60) GRM4CYP1A2RAB9ANPC1ALDH1A1
SCHEMBL29699887 0.69 CYP1A2 (0.60) GRM4CYP1A2RAB9ANPC1ALDH1A1
SCHEMBL27917128 0.69 CYP1A2 (0.60) GRM4CYP1A2RAB9ANPC1ALDH1A1
SCHEMBL26269813 0.68 ALDH1A1 (0.47) GRM4CYP1A2RAB9ANPC1ALDH1A1
SCHEMBL10028161 0.68 MCL1 (0.37) CYP1A2RAB9AALDH1A1KDM4EHPGD
SCHEMBL13861776 0.67 CYP1A2 (0.47) GRM4CYP1A2RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046915-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-12-02 EP disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 GRM4 2206/4885CYP1A2 1150/4885RAB9A 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.